CytoCares
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
no.11 Jialilue Rd, Pudong New District, ...Phone Number
+86 2150710105Website
www.cytocares.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About CytoCares
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CytoCares your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CytoCares has new funding data
Check out if CytoCares is spiking on competitors!
Product Launch: Get notified when CytoCares launches new products
CytoCares, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CytoCares recently announced quarterly report
Click to see if CytoCares had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CytoCares
Check if CytoCares has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at CytoCares
Find 3 more new buyers
Company Profile Activity
Activity Insights
CytoCares is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CytoCares is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CytoCares.
CytoCares Tech Stack
A closer look at the technologies used by CytoCares
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CytoCares
惠和生物技术（上海）有限公司 specializes in the development of multi-specific antibody drugs, focusing on innovative therapies for cancer treatment. Their platforms, including TriTE, CCNK, and CCMφ, are designed to activate T cells, NK cells, and macrophages to enhance anti-tumor immunity. The company has a robust pipeline, with their first-in-class tri-specific... Read More
